Overview
- 5 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-03-07.
At a glance
Inspections
5
Form 483s
5
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 3 Mar 2025 – 7 Mar 2025 | Human Drugs | 483 | On file |
| 23 Apr 2019 – 26 Apr 2019 | Human Drugs | 483 | On file |
| 9 May 2016 – 11 May 2016 | Human Drugs | 483 | View 483 → |
| 14 Jan 2011 | Not recorded | 483 | View 483 → |
| 5 Sep 2008 | Not recorded | WL | On file |
Observations on record
Form 483 observations cited at this site, most recent first.
11 May 2016
21 CFR 211.188(b)
Batch production and Batch Control Record Requirements
Cited by Torrance J Slayton
Investigators
FDA investigators tied to this site in the record.
Robin P Mathew1 insp.
Soyinka S Eneng1 insp.
Latorie S Jones1 insp.
Torrance J Slayton1 insp.
Michael A Charles1 insp.
Carla J Lundi1 insp.
Katherine Szestypalow1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.122(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(8) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Laboratoire Atlas Inc's 5 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat